Delivery Order SPE2DR25D2014-SPE2DR26FA1L1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,142.18 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 7, 2026, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,170.35 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (60 count), a combination inhalation powder used to treat chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,665.23 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This non-competitive delivery order represents a firm fixed price transaction with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,347.03 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This non-competitive, firm fixed-price delivery order is set to be completed by October 28, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The order represents a small-value...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The order, valued at $1,220.18 with a firm fixed price structure, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of January 6, 2026. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,046.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The award, issued December 1, 2025, with completion targeted for December 2, 2025, was made on a firm fixed-price basis without set-aside restrictions, indicating competitive award through open procurement. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for pharmaceutical supplies valued at $2,186.63. The order is for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle and reflects the...
- The Defense Logistics Agency awarded a delivery order valued at $5,758.80 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed price delivery order with an ultimate completion date of November 25, 2025, and was competitively awarded without a set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1L1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,702.52 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by January 7, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2031. This comprehensive IDC vehicle enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract reflects AmerisourceBergen's established capability to efficiently fulfill federal pharmaceutical supply requirements for military treatment facilities and other government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 1/5/26 |